Related Experiment Videos
Preventable medication-related events in hospitalised children in New Zealand
Desireé L Kunac1, David M Reith
1School of Pharmacy, University of Otago, Dunedin, New Zealand. desiree.kunac@otago.ac.nz
Insights
Preventable medication errors are frequent in hospitalized children, with over half of harmful events being avoidable. Dosing errors and antibacterial use, especially intravenous, are key targets for prevention.
Area of Science:
- Pediatric pharmacology
- Patient safety
- Healthcare quality improvement
Background:
- Medication-related events (MREs) pose a significant risk to hospitalized children.
- Identifying and preventing these events is crucial for improving pediatric patient safety.
Purpose of the Study:
- To assess the incidence and characteristics of preventable MREs in pediatric inpatients.
- To evaluate the effectiveness of different methods for detecting MREs.
- To identify priority areas for preventing MREs in children.
Main Methods:
- A 12-week prospective observational cohort study in a New Zealand pediatric ward.
- Multifaceted approach to identify MREs, including chart review, voluntary reporting, parent interviews, and incident reporting.
- Independent classification of MREs by three reviewers.
Main Results:
- A high rate of preventable MREs was observed, with 92.2% of analyzed events being preventable.
- Adverse Drug Events (ADEs) and potential ADEs were largely preventable (56.7% and 97.4%, respectively).
- Improper dosing during prescribing and the use of antibacterial agents via intravenous administration were most frequently implicated in harmful events.
Conclusions:
- Preventable MREs are common in pediatric inpatients, with significant potential for harm.
- Chart review is more effective than voluntary or incident reporting for identifying MREs.
- Targeting dosing errors and intravenous antibacterial use can significantly reduce preventable harm.
Aims:
To evaluate the frequency and characteristics of preventable medication-related events in hospitalised children, to determine the yield of several methods for identifying them and to recommend priorities for prevention.
Methods:
A prospective observational cohort study was conducted over a 12-week period on the paediatric wards at a university-affiliated urban general hospital in New Zealand. For all admissions of greater than 24 hours, medication-related events were identified using a multifaceted approach and subsequently classified independently by three reviewers (using a standardised reviewer form) by event type, type of error, stage of the medication process, and preventability.
Results:
There were 495 eligible study patients, who had 520 admissions and 3037 patient days of admission, during which 3160 medication orders were written. Of 761 medication-related events reported during the study period, 630 (83.3%) were identified by chart review; 111 (14.6%) by a voluntary staff quality improvement reporting system; 16 (2.1%) by interview of parents; and 4 (0.53%) events via the concurrent routine hospital-incident reporting system. Excluding duplicate reports and practice-related issues, a total of 696 study patient-specific events were included in the analysis. Excluding the inconsequential events (trivial rule violation and 'other' categories), the majority [368/399 (92.2%)] of events were found to be preventable; comprising 38/67 (56.7%) ADEs, 75/77 (97.4%) potential ADEs, and all 255 (100%) harmless medication errors. Most commonly implicated in preventable ADEs and potential ADEs were, event rate (95%CI): improper dose and the prescribing stage-35 (29 to 42) and 74 (64 to 84) respectively per 1000 patient days; and antibacterial agents and the intravenous route of administration 21 (17 to 25) and 11 (10 to 13) respectively per 100 medication orders.
Conclusions:
Preventable medication-related events occur commonly in the paediatric inpatient setting, and importantly over half of the events that caused patient harm were deemed preventable. Voluntary staff reporting in a quality improvement environment was found to be inferior to chart review for identifying events, but a vast improvement on the conventional incident reporting system. Most commonly implicated in the harmful or potentially harmful preventable events, and hence the best targets for prevention are dosing errors, particularly during the prescribing stage of the medication use process, and use of antibacterial agents, particularly when administered by the intravenous route.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmacokinetics in Pediatric Patients: Drug Excretion
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children